RENAISSANCE TECHNOLOGIES LLC

Position in ALT — Altimmune, Inc.

CIK 1037389 NEW YORK, NY

Position in ALT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$217,664

-$642,676 QoQ

Shares Held

71,600

-78.4% QoQ

Ownership

0.037%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#86

of 210 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. ALT ranks #248 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$217,664	71,600	-78.4%	Shares	Sole	2026-08-13
2023-09-30	$860,340	330,900	-49.8%	Shares	Sole	2023-11-14
2023-06-30	$2,325,211	658,700	+138.4%	Shares	Sole	2023-08-11
2023-03-31	$1,165,986	276,300	-45.6%	Shares	Sole	2023-05-12
2022-12-31	$8,356,600	508,000	-49.1%	Shares	Sole	2023-02-13
2022-09-30	$12,747,014	998,200	+50.0%	Shares	Sole	2022-11-14
2022-06-30	$7,785,180	665,400	+71.2%	Shares	Sole	2022-08-12
2022-03-31	$2,367,183	388,700	+481.9%	Shares	Sole	2022-05-13
2021-12-31	$611,888	66,800	-93.5%	Shares	Sole	2022-02-11
2020-09-30	$13,523,492	1,024,507	+10.7%	Shares	Sole	2020-11-13
2020-06-30	$9,914,321	925,707	+50.0%	Shares	Sole	2020-08-13
2020-03-31	$1,980,592	617,007	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.